Nanoco Group PLC Director Declaration (8513G)
20 March 2020 - 2:00AM
UK Regulatory
TIDMNANO
RNS Number : 8513G
Nanoco Group PLC
19 March 2020
19 March 2020
NANOCO GROUP PLC
(" Nanoco ", the "Group", or the "Company" )
Director Declaration
Nanoco Group plc (LSE: NANO), a world leader in the development
and manufacture of cadmium-free quantum dots and other specific
nanomaterials emanating from our technology platform, makes the
following announcement .
In accordance with Listing Rule 9.6.14 the Company announces
that Non-Executive Director, Dr Alison Fielding is to take up a
non-executive director role with Zotefoams plc with effect from 14
May 2020.
There are no further disclosures required to be made in respect
of Rule 9.6.13 of the Listing Rules.
For further information, please contact:
Nanoco Tel: +44 (0) 161 603 7900
Brian Tenner, Company Secretary
Caroline Watson, Investor Relations Tel: + 44 (0) 7799 897357
Manager
cwatson@nanocotechnologies.com
Notes for editors:
About Nanoco Group plc
Nanoco (LSE: NANO) harnesses the power of nano-materials.
Nano-materials are materials with dimensions typically in the range
1 - 100 nm. Nano-materials have a range of useful properties,
including optical and electronic. Quantum dots are a subclass of
nano-material that have size-dependent optical and electronic
properties. The Group produces quantum dots. Within the sphere of
quantum dots, the Group exploits different characteristics of the
quantum dots to target different performance criteria that are
attractive to specific markets or end-user applications such as the
Display and Electronics markets. One of the interesting properties
of quantum dots is photoluminescence: the emission of longer
wavelength light upon excitation by light of a shorter wavelength.
The colour of light emitted depends on the particle size. Nanoco's
CFQD (R) quantum dots are free of cadmium and other toxic heavy
metals, and can be tuned to emit light at different wavelengths
across the visible and infrared spectrum, rendering them useful for
a wide range of applications including displays, lighting and
biological imaging.
Nanoco has non-exclusive manufacturing and marketing licensing
agreements in display with The Dow Chemical Company, Merck KGaA of
Germany and Wah Hong Industrial Corporation of Taiwan.
Nanoco was founded in 2001 and is headquartered in Manchester,
UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco
continues to build out a world-class, patent-protected IP portfolio
generated both by its own innovation engine, as well as through
acquisition.
Nanoco is listed on the Main Market of the London Stock Exchange
and trades under the ticker symbol NANO. For further information
please visit: www.nanocogroup.com .
- Ends -
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RDNBSGDXDUBDGGC
(END) Dow Jones Newswires
March 19, 2020 11:00 ET (15:00 GMT)
Nanoco (AQSE:NANO.GB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nanoco (AQSE:NANO.GB)
Historical Stock Chart
From Jul 2023 to Jul 2024